Dr. Lindsay McNair is an experienced pharmaceutical physician with a thorough understanding of the integration of science, medicine and business necessary for drug development and marketing. Dr. McNair has more than 12 years of experience in clinical research and drug development strategy. She has designed and provided medical monitoring for Phase 1, 2 and 3 clinical studies in a variety of therapeutic areas, including multiple oncology indications, hepatitis C, multiple inflammation indications (psoriasis, multiple sclerosis) and other areas.
Dr. McNair is an adjunct Assistant Professor at Boston University and teaches in the School of Public Health and in the Master’s of Clinical Investigation graduate programs, on the design and conduct of clinical research studies. Dr. McNair has a strong interest in bioethics, and has spoken at multiple conferences about the ethical conduct of clinical research studies as part of pharmaceutical drug development, and improving interactions between ethics committees/ research review boards and the pharmaceutical industry.
Dr. McNair graduated from the University Of Connecticut School Of Medicine and trained in general surgery at Boston University Medical Center. She completed her Master’s in Public Health at the Boston University School of Public Health, concentrating in both Biostatistics/Epidemiology and Health Services Administration. She is currently enrolled in the Master’s in Bioethics program of Union Graduate College/ Mt. Sinai Medical School, with a concentration in research ethics. She was a member of the Institutional Review Board for the conduct of clinical research at Boston University Medical Center for several years, and founded and chaired the Human Subject Protection Committee at Vertex Pharmaceuticals. She is an active member of PRIM&R (a national research ethics association). She was a site visitor for the Association for the Accreditation of Human Research Protection Programs (AAHRPP).